Beta Drugs IPO Latest News Today

Track all the latest updates and news of Beta Drugs IPO.

1. Ibotta: New IPO With Strong Growth

   April 19, 2024 6:30:00 PM

   The company raised around $200 million in its IPO, despite the overall size being $600 million. Ibotta is a profitable digital marketing company that allows consumer packaged goods companies to ...

   Published by : Seeking Alpha

2. Boundless Bio boldly goes public with $100M IPO

   March 28, 2024 10:40:00 AM

   An investigational new drug application for a third program isn't expected to be filed until the first half of 2026. Boundless isn�t the only biotech IPO set for spring. Contineum Therapeutics ...

   Published by : FierceBiotech

3. Weight loss biotech plans IPO as demand builds for anti-obesity treatments

   March 29, 2024 3:30:00 AM

   An IPO could happen as early as late July as the company looks to cash in on investor excitement about the next generation of weight-loss drugs and a revival in the biotech IPO market. A total of ...

   Published by : The Financial Times

4. Contineum prices biotech�s latest IPO, raising $110M for neuroinflammatory drugs

   April 4, 2024 3:30:00 AM

   By this time last year, only four drug startups had gone public, raising $375 million. In 2022, nine companies had pulled in $744 million. The IPO activity has been accompanied by a step-up in ...

   Published by : Yahoo Finance

5. Apogee Catapults 42% After Eczema Drug Blows Expectations Out Of The Water

   March 5, 2024 3:17:00 PM

   IPO Stock Faces Competition Apogee is facing some competition in eczema treatment, however. It's going up against Eli Lilly's drug, lebrikizumab. Both drugs target IL-13, a critical cytokine in ...

   Published by : MSN

6. Boundless Bio�s �BOLD� IPO Reels In $100M for a New Kind of Cancer Drug

   March 28, 2024 4:45:00 PM

   The company has developed a diagnostic to identify patients amenable to treatment with an ecDNA-directed drug. In the IPO filing, the company said it is working with an in vitro diagnostic company ...

   Published by : MedCity News

7. MS drug developer Contineum files for $150M IPO

   March 19, 2024 10:10:00 PM

   Based in San Diego, the company has two drugs in early-to-mid stage clinical development. The company just completed a Phase 1 study for its candidate PIPE-791 for MS and IPF. Its second candidate ...

   Published by : Seeking Alpha

8. Nasdaq IPO Pulse Index

   January 24, 2024 4:00:00 PM

   The new Nasdaq IPO Pulse Index functions as a leading indicator for the IPO Market by forecasting the direction of US IPO activity over the next six months. IPO activity rises and falls in cycles.

   Published by : Nasdaq

9. IPO News

   April 3, 2024 3:29:00 AM

   The financial loss comes days after reports of Bithumb facing potential internal issues that led to the delay of its planned IPO. Bitkub targets to go public on the Stock Exchange of Thailand in ...

   Published by : CoinTelegraph

10. IPO Corner

    April 22, 2024 3:30:00 AM

    IIFL Securities and ICICI Securities are the book running lead managers for the JNK India IPO, while Link Intime India is the registrar for the issue. Nephro Care IPO: Nephro Care India Ltd has ...

    Published by : Business Today

11. Contineum prices biotech�s latest IPO, raising $110M for neuroinflammatory drugs

    April 10, 2024 11:07:00 AM

    By this time last year, only four drug startups had gone public, raising $375 million. In 2022, nine companies had pulled in $744 million. The IPO activity has been accompanied by a step-up in funding ...

    Published by : Yahoo Finanzas

Beta Drugs IPO Alerts